Reaction
Spinal Cord Neoplasm reporting signals
As of the last recalculation, Spinal Cord Neoplasm appears in 866 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is OCTREOTIDE ACETATE (PRR 22.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Octreotide Acetate | 28 | 22.7 | 22.7 |
| Lanreotide Acetate | 6 | 18.5 | 18.5 |
| Ribociclib | 20 | 15.6 | 15.6 |
| Pazopanib Hydrochloride | 10 | 9.0 | 9.0 |
| Enzalutamide | 21 | 8.8 | 8.8 |
| Selinexor | 3 | 8.4 | 8.4 |
| Vismodegib | 3 | 8.1 | 8.1 |
| Abiraterone Acetate | 12 | 7.1 | 7.1 |
| Pomalidomide | 17 | 4.0 | 4.0 |